bioflavonoid quercetin is well tolerated and provides significant symptomatic improvement in most men with chronic pelvic pain syndrome.

I told you, the 40x, 50x, 100x increase in absorption and bioavailability of Curcumin, Quercetin, Lipoic Acid, Vitamin C, Berberine, Glutathione, Pycnogenol, CBD, B Complex, etc is going to cut Pharma in half, better than 50% of their poison will become obsolete. I'm not wrong. pic.twitter.com/joMx7rbMNA

— DCGreenZone1 (@DCGreenZone) September 9, 2022

From PubMed,

Both the quercetin and placebo groups were similar in age, symptom duration, and initial symptom score. Patients taking placebo had a mean improvement in NIH symptom score from 20.2 to 18.8 (not significant), while those taking the bioflavonoid had a mean improvement from 21.0 to 13.1 (P = 0.003). Twenty percent of patients taking placebo and 67% of patients taking the bioflavonoid had an improvement of symptoms of at least 25%. In the 17 patients who received Prosta-Q in the open-label study, 82% had at least a 25% improvement in symptom score.

Conclusions: Therapy with the bioflavonoid quercetin is well tolerated and provides significant symptomatic improvement in most men with chronic pelvic pain syndrome.